These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 39297933)
1. Association of in vivo retention of [ Freiburghaus T; Pawlik D; Oliveira Hauer K; Ossenkoppele R; Strandberg O; Leuzy A; Rittmo J; Tremblay C; Serrano GE; Pontecorvo MJ; Beach TG; Smith R; Hansson O Acta Neuropathol; 2024 Sep; 148(1):44. PubMed ID: 39297933 [TBL] [Abstract][Full Text] [Related]
2. 18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases. Soleimani-Meigooni DN; Iaccarino L; La Joie R; Baker S; Bourakova V; Boxer AL; Edwards L; Eser R; Gorno-Tempini ML; Jagust WJ; Janabi M; Kramer JH; Lesman-Segev OH; Mellinger T; Miller BL; Pham J; Rosen HJ; Spina S; Seeley WW; Strom A; Grinberg LT; Rabinovici GD Brain; 2020 Dec; 143(11):3477-3494. PubMed ID: 33141172 [TBL] [Abstract][Full Text] [Related]
3. Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology. Smith R; Wibom M; Pawlik D; Englund E; Hansson O JAMA Neurol; 2019 Mar; 76(3):310-317. PubMed ID: 30508025 [TBL] [Abstract][Full Text] [Related]
4. Associations between quantitative [ Timmers T; Ossenkoppele R; Wolters EE; Verfaillie SCJ; Visser D; Golla SSV; Barkhof F; Scheltens P; Boellaard R; van der Flier WM; van Berckel BNM Alzheimers Res Ther; 2019 Jul; 11(1):60. PubMed ID: 31272512 [TBL] [Abstract][Full Text] [Related]
5. Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration. Ghirelli A; Tosakulwong N; Weigand SD; Clark HM; Ali F; Botha H; Duffy JR; Utianski RL; Buciuc M; Murray ME; Labuzan SA; Spychalla AJ; Pham NTT; Schwarz CG; Senjem ML; Machulda MM; Baker M; Rademakers R; Filippi M; Jack CR; Lowe VJ; Parisi JE; Dickson DW; Josephs KA; Whitwell JL Ann Neurol; 2020 Nov; 88(5):1009-1022. PubMed ID: 32869362 [TBL] [Abstract][Full Text] [Related]
6. Associations between near end-of-life flortaucipir PET and postmortem CTE-related tau neuropathology in six former American football players. Alosco ML; Su Y; Stein TD; Protas H; Cherry JD; Adler CH; Balcer LJ; Bernick C; Pulukuri SV; Abdolmohammadi B; Coleman MJ; Palmisano JN; Tripodis Y; Mez J; Rabinovici GD; Marek KL; Beach TG; Johnson KA; Huber BR; Koerte I; Lin AP; Bouix S; Cummings JL; Shenton ME; Reiman EM; McKee AC; Stern RA; Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):435-452. PubMed ID: 36152064 [TBL] [Abstract][Full Text] [Related]
7. Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes. Fleisher AS; Pontecorvo MJ; Devous MD; Lu M; Arora AK; Truocchio SP; Aldea P; Flitter M; Locascio T; Devine M; Siderowf A; Beach TG; Montine TJ; Serrano GE; Curtis C; Perrin A; Salloway S; Daniel M; Wellman C; Joshi AD; Irwin DJ; Lowe VJ; Seeley WW; Ikonomovic MD; Masdeu JC; Kennedy I; Harris T; Navitsky M; Southekal S; Mintun MA; JAMA Neurol; 2020 Jul; 77(7):829-839. PubMed ID: 32338734 [TBL] [Abstract][Full Text] [Related]
8. Direct Comparison of the Tau PET Tracers Gogola A; Minhas DS; Villemagne VL; Cohen AD; Mountz JM; Pascoal TA; Laymon CM; Mason NS; Ikonomovic MD; Mathis CA; Snitz BE; Lopez OL; Klunk WE; Lopresti BJ J Nucl Med; 2022 Jan; 63(1):108-116. PubMed ID: 33863821 [TBL] [Abstract][Full Text] [Related]
9. Flortaucipir PET uncovers relationships between tau and amyloid-β in primary age-related tauopathy and Alzheimer's disease. Josephs KA; Tosakulwong N; Weigand SD; Graff-Radford J; Schwarz CG; Senjem ML; Machulda MM; Kantarci K; Knopman DS; Nguyen A; Reichard RR; Dickson DW; Petersen RC; Lowe VJ; Jack CR; Whitwell JL Sci Transl Med; 2024 Jul; 16(757):eado8076. PubMed ID: 39047115 [TBL] [Abstract][Full Text] [Related]
10. Detection of tau in Gerstmann-Sträussler-Scheinker disease (PRNP F198S) by [ Risacher SL; Farlow MR; Bateman DR; Epperson F; Tallman EF; Richardson R; Murrell JR; Unverzagt FW; Apostolova LG; Bonnin JM; Ghetti B; Saykin AJ Acta Neuropathol Commun; 2018 Oct; 6(1):114. PubMed ID: 30373672 [TBL] [Abstract][Full Text] [Related]
11. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition. Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA; Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397 [TBL] [Abstract][Full Text] [Related]
14. Test-Retest Reproducibility for the Tau PET Imaging Agent Flortaucipir F 18. Devous MD; Joshi AD; Navitsky M; Southekal S; Pontecorvo MJ; Shen H; Lu M; Shankle WR; Seibyl JP; Marek K; Mintun MA J Nucl Med; 2018 Jun; 59(6):937-943. PubMed ID: 29284675 [TBL] [Abstract][Full Text] [Related]
15. Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults. McSweeney M; Pichet Binette A; Meyer PF; Gonneaud J; Bedetti C; Ozlen H; Labonté A; Rosa-Neto P; Breitner J; Poirier J; Villeneuve S; Neurology; 2020 Mar; 94(11):e1190-e1200. PubMed ID: 32015176 [TBL] [Abstract][Full Text] [Related]
16. Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks. Schumacher J; Gunter JL; Przybelski SA; Jones DT; Graff-Radford J; Savica R; Schwarz CG; Senjem ML; Jack CR; Lowe VJ; Knopman DS; Fields JA; Kremers WK; Petersen RC; Graff-Radford NR; Ferman TJ; Boeve BF; Thomas AJ; Taylor JP; Kantarci K Brain; 2021 Nov; 144(10):3212-3225. PubMed ID: 34114602 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858 [TBL] [Abstract][Full Text] [Related]
18. Association of Initial β-Amyloid Levels With Subsequent Flortaucipir Positron Emission Tomography Changes in Persons Without Cognitive Impairment. Knopman DS; Lundt ES; Therneau TM; Albertson SM; Gunter JL; Senjem ML; Schwarz CG; Mielke MM; Machulda MM; Boeve BF; Jones DT; Graff-Radford J; Vemuri P; Kantarci K; Lowe VJ; Petersen RC; Jack CR; JAMA Neurol; 2021 Feb; 78(2):217-228. PubMed ID: 33074304 [TBL] [Abstract][Full Text] [Related]
20. Compensating for choroid plexus based off-target signal in the hippocampus using Pawlik D; Leuzy A; Strandberg O; Smith R Neuroimage; 2020 Nov; 221():117193. PubMed ID: 32711062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]